Stocks · Healthcare · Biotechnology
Invivyd, Inc. IVVD
$0.84 +2.08% Close, Oct 5, 2026 · NASDAQ · Market cap $242.2M
Weak trendHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -192.8% from -245.7% a year earlier.
- The diluted share count rose 167.0% in a year.
- The stock is 71% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 26%
- Revenue growth accelerationBottom 10%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 21%
- Gross marginTop 17%
- Operating marginBottom 24%
- Accruals (lower is better)Bottom 15%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 16%
- Free-cash-flow yieldBottom 10%
- EBITDA / enterprise valueBottom 4%
- Sales / enterprise valueTop 18%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 17%
- 6-month returnBottom 13%
- 1-year return vs S&P 500Bottom 22%
- Distance from 52-week highBottom 7%
- Trend checklist (0–4)Bottom 36%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 47%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 27%
- Upside to consensus price targetTop 2%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 6%
- Maximum drawdown, 3 yearsBottom 9%
- Beta vs S&P 500 (lower is better)Bottom 26%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 52.3% | 26.3% | ↓ |
| Gross margin | 93.4% | 91.4% | ↓ |
| Operating margin | -245.7% | -192.8% | ↑ |
| FCF margin | -245.1% | -187.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 26.3% | 52.3% | ↓ | Top 26% |
| Gross margin | 91.4% | 93.4% | ↓ | Top 17% |
| Operating margin | -192.8% | -245.7% | ↑ | Bottom 24% |
| Net margin | -183.9% | -238.3% | ↑ | — |
| Free-cash-flow margin | -187.9% | -245.1% | ↑ | — |
| Return on invested capital | -59.4% | — | Bottom 21% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 0.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 19.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -97.05%
- Shareholder yield
- -97.05%
- Share count change, 1 year
- +167.0%
- Share count change, 3-year CAGR
- +43.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- +4.9%
- Average 2-day reaction, last 8
- -6.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $9.50
- Target vs current price
- +1032.0%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 63%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -31.2% | -6.3% | +31.1% | +6.0% | — |
| May 14, 2026 | -62.5% | -21.1% | -25.9% | -44.7% | -54.2% |
| Mar 5, 2026 | +133.3% | +1.8% | +11.1% | -22.2% | -33.3% |
| Nov 6, 2025 | -20.0% | +1.3% | +16.4% | +46.1% | +23.7% |
| Aug 14, 2025 | -200.0% | +0.8% | -20.1% | +55.1% | +94.2% |
| May 15, 2025 | -250.0% | -15.8% | -8.5% | +1.3% | -7.9% |
| Mar 20, 2025 | +40.0% | +2.6% | -14.5% | -34.5% | +10.0% |
| Nov 14, 2024 | -54.5% | -11.2% | -13.7% | -34.8% | +70.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.14 | -$0.11 | -31.2% | $14.3M |
| May 14, 2026 | -$0.13 | -$0.08 | -62.5% | $13.7M |
| Mar 5, 2026 | $0.02 | -$0.06 | +133.3% | $17.2M |
| Nov 6, 2025 | -$0.06 | -$0.05 | -20.0% | $13.1M |
| Aug 14, 2025 | -$0.12 | -$0.04 | -200.0% | $11.8M |
| May 15, 2025 | -$0.14 | -$0.04 | -250.0% | $11.3M |
| Mar 20, 2025 | -$0.15 | -$0.25 | +40.0% | $13.8M |
| Nov 14, 2024 | -$0.51 | -$0.33 | -54.5% | $9.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.55× | — | — | Top 18% |
| Free-cash-flow yield | -45.28% | — | — | Bottom 10% |
| Earnings yield | -46.99% | — | — | Bottom 16% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 11
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +3.4%
- 200-day average slope (20 days)
- -10.1%
- Distance from 50-day average
- +4.7%
- Distance from 200-day average
- -37.5%
- RSI (14)
- 48.6
- Relative volume
- 0.77×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 112.4%
- Volatility vs own 5-year history
- 51th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.65
- Correlation with S&P 500
- 0.07
- Current drawdown from 1-year high
- -70.9%
- Maximum drawdown, 3 years
- -92.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 16, 2021 | Jan 31, 2025 | -99.4% | 847 days | Not yet recovered |
| Sep 10, 2021 | Sep 13, 2021 | -20.2% | 1 days | 2 days (Sep 15, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $242.2M
- EPS, diluted (TTM)
- -$0.39
- Revenue (TTM)
- $58.4M
- 52-week range
- $0.53 – $3.07
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $25.4M | $53.4M |
| Gross profit | $0 | $0 | $0 | $23.8M | $49.7M |
| Operating income | -$226.9M | -$248.0M | -$212.8M | -$176.9M | -$55.6M |
| Net income | -$226.8M | -$241.3M | -$198.6M | -$169.9M | -$52.5M |
| EPS (diluted) | -$2.11 | -$2.17 | -$1.81 | -$1.43 | -$0.30 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.3M | $13.8M | $11.3M | $11.8M | $13.1M | $17.2M | $13.7M | $14.3M |
| Net income | -$60.7M | -$18.4M | -$16.3M | -$14.7M | -$10.5M | -$11.1M | -$41.4M | -$44.4M |
| EPS (diluted) | -$0.51 | -$0.15 | -$0.14 | -$0.12 | -$0.06 | -$0.06 | -$0.13 | -$0.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$184.7M | -$220.0M | -$173.2M | -$170.5M | -$58.1M |
| Capital expenditure | -$84,000 | -$1.7M | -$615,000 | -$140,000 | -$155,000 |
| Free cash flow | -$184.8M | -$221.7M | -$173.8M | -$170.6M | -$58.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $330.9M | $506,000 | $1.2M | $39.9M | $215.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $160.1M
- Total assets
- $218.9M
- Total liabilities
- $37.8M
- Total debt
- $8.4M
- Net debt
- -$151.7M
- Shareholders’ equity
- $181.1M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 30,556,394
- Days to cover
- 7.70
- Change vs previous report
- +2.6%
FINRA short interest, settlement date Sep 15, 2026.